Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Aug 13, 2023 10:51pm

191 Views

Post# 35586396

FDA approval OPENED the door for LABS to ship

to PHASE II trials. Phase II trials involve humans so the source of the drug supplying to the Phase 2 has to be FDA approved.

FDA approval Q1, 2023. Big jump in shipping to Phase 2 trials now. Earnings surprise tomorrow?

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week